Indicațiile actuale ale combinației terapeutice sacubitril/valsartan în insuficiența cardiacă | [Current indications for sacubitril/valsartan therapeutic combination in heart failure]
Abstract:The prevalence of heart failure has increased globally in recent decades. Nowadays, life expectation and quality of life of these patients has increased thanks to innovative therapies. The inhibitors of AG II receptors and neprilysin inhibitors demonstrate a high clinical value against the progression of heart failure targeting the neurohormonal pathways. This therapy has been shown to contribute to a step-wise reduction in mortality and morbidity in heart failure with reduced ejection fraction (HFrEF) patient… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.